This study is NOT currently recruiting participants.
Number
04-AR-0205
Sponsoring Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruitment Detail
Type: Completed Study; data analyses ongoing Gender: Male & Female Min Age: 18 Years Max Age: N/A
Referral Letter Required
No
Population Exclusion(s)
Children
Keywords
Syndesmophyte; Natural History
Recruitment Keyword(s)
Ankylosing Spondylitis; AS; Spondyloarthropathy; Spondyloarthritis
Condition(s)
Ankylosing Spondylitis
Investigational Drug(s)
None
Investigational Device(s)
Intervention(s)
Supporting Site
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Patients 18 years of age and older with ankylosing spondylitis who are not currently taking or planning to receive treatment with anti-TNF alpha medications (etanercept, infliximab, adalimumab) for 1 year may be eligible for this study. Participants have eight clinic visits, scheduled at study entry and at 4, 8, 12, 16, 20, 24, and 48 months, at the NIH Clinical Center for the following procedures:
-Clinical assessment (all visits) - includes medical history and physical examination, measurement of spine flexibility with a tape measure and protractor, symptoms questionnaire
-Blood tests for measures of inflammation, including red blood cell sedimentation rate and C-reactive protein level (all visits)
-Urine pregnancy test in women of child-bearing age (visits 1, 4, 7, 8)
-X-rays of the pelvis, low back, and neck (visits 1, 4, 7)
-X-ray of the low back (visit 8)
-CT scan of the low back (visits 1, 4, 7)
-Magnetic resonance imaging (MRI) of the low back (visits 1, 4) - MRI combines a powerful magnet with an advanced computer system and radio waves to produce accurate, detailed pictures of organs and tissues. The patient lies on a table in a narrow cylinder containing a magnetic field, wearing earplugs to muffle loud noises that occur with electrical switching of the magnetic fields. He or she can speak with a staff member via an intercom system at all times during the procedure. During the scan, a contrast dye (gadolinium) is injected into the bloodstream through a catheter (plastic tube inserted in a vein) to brighten the images.
In addition, participants will complete a symptoms questionnaire by mail every 4 months for 2 years between visits 7 and 8.
--Back to Top--
A. LONGITUDINAL STUDY PROTOCOL: Fifty-five patients will be studied. INCLUSION CRITERIA: 1. Age 18 years or older 2. Diagnosis of AS by the modified New York criteria 3. Lumbar spine BASRI score of 0, 1, 2, or 3 We will aim to recruit at least 6 patients in each of the following BASRI lumbar spine categories: - 0 or 1 (normal or suspicious changes) - 2 (erosions, sclerosis or squaring with or without syndesmophytes or 2 or fewer vertebrae) - 3 (syndesmophytes on 3 or more vertebrae with fusion of at most 2 vertebrae) EXCLUSION CRITERIA: 1. Inability to provide informed consent. 2. BASRI lumbar spine score of 4 (complete fusion; 12) 3. Contraindication to MRI scanning based on the NMR Center MRI Safety Screening Questionnaire or size or weight limitations of the scanner. 4. History of allergic reactions to gadolinium-DPTA contrast used for MRI 5. Anticipated unavailability for follow-up over 2 years 6. Pregnancy 7. Onset of AS at age 16 or younger 8. Spondyloarthropathy other than AS 9. Severe scoliosis or other spinal malalignment that would complicate scan interpretation B. CROSS-SECTIONAL (RELIABILITY) STUDY PROTOCOL Up to 35 patients will be studied. INCLUSION CRITERIA: 1. Age 18 years or older 2. Diagnosis of AS by the modified New York criteria (5) EXCLUSION CRITERIA: 1. Inability to provide informed consent 2. BASRI lumbar spine score of 4 (complete fusion)<TAB> 3. Pregnancy 4. Onset of AS at age 16 or younger 5. Spondyloarthropathy other than AS 6. Severe scoliosis or other spinal malalignment that would complicate scan interpretation
Fifty-five patients will be studied.
INCLUSION CRITERIA:
1. Age 18 years or older
2. Diagnosis of AS by the modified New York criteria
3. Lumbar spine BASRI score of 0, 1, 2, or 3
We will aim to recruit at least 6 patients in each of the following BASRI lumbar spine categories:
- 0 or 1 (normal or suspicious changes)
- 2 (erosions, sclerosis or squaring with or without syndesmophytes or 2 or fewer vertebrae)
- 3 (syndesmophytes on 3 or more vertebrae with fusion of at most 2 vertebrae)
EXCLUSION CRITERIA:
1. Inability to provide informed consent.
2. BASRI lumbar spine score of 4 (complete fusion; 12)
3. Contraindication to MRI scanning based on the NMR Center MRI Safety Screening Questionnaire or size or weight limitations of the scanner.
4. History of allergic reactions to gadolinium-DPTA contrast used for MRI
5. Anticipated unavailability for follow-up over 2 years
6. Pregnancy
7. Onset of AS at age 16 or younger
8. Spondyloarthropathy other than AS
9. Severe scoliosis or other spinal malalignment that would complicate scan interpretation
B. CROSS-SECTIONAL (RELIABILITY) STUDY PROTOCOL
Up to 35 patients will be studied.
2. Diagnosis of AS by the modified New York criteria (5)
1. Inability to provide informed consent
2. BASRI lumbar spine score of 4 (complete fusion)<TAB>
3. Pregnancy
4. Onset of AS at age 16 or younger
5. Spondyloarthropathy other than AS
6. Severe scoliosis or other spinal malalignment that would complicate scan interpretation
Principal Investigator
Referral Contact
For more information: